Perkins Daniel, Schubert Violeta, Simonová Hana, Tófoli Luís Fernando, Bouso José Carlos, Horák Miroslav, Galvão-Coelho Nicole Leite, Sarris Jerome
School of Social and Political Science, University of Melbourne, Melbourne, VIC, Australia.
Independent Researcher, Melbourne, VIC, Australia.
Front Pharmacol. 2021 Apr 21;12:623979. doi: 10.3389/fphar.2021.623979. eCollection 2021.
Ayahuasca is a traditional plant decoction containing N,N-dimethyltryptamine (DMT) and various β-carbolines including harmine, harmaline, and tetrahydroharmine, which has been used ceremonially by Amazonian Indigenous groups for healing and spiritual purposes. Use of the brew has now spread far beyond its original context of consumption to North America, Europe, and Australia in neo-shamanic settings as well as Christian syncretic churches. While these groups have established their own rituals and protocols to guide use, it remains unknown the extent to which the use of traditional or non-traditional practices may affect drinkers' acute experiences, and longer term wellbeing and mental health outcomes. Hence, this study aimed to provide the first detailed assessment of associations between ceremony/ritual characteristics, additional support practices, motivations for drinking, and mental health and wellbeing outcomes. The paper uses data from a large cross-sectional study of ayahuasca drinkers in more than 40 countries who had used ayahuasca in various contexts ( = 6,877). It captured detailed information about participant demographics, patterns and history of ayahuasca drinking, the setting of consumption, and ritualistic practices employed. Current mental health status was captured via the Kessler 10 psychological distress scale and the mental health component score of the SF-12 Health Questionnaire, while reported change in prior clinically diagnosed anxiety or depression ( = 1276) was evaluated using a (PGIC) Patient Global Impression of Change tool. Various intermediate outcomes were also assessed including perceived change in psychological wellbeing, number of personal self-insights attained, and subjective spiritual experience measured via the spirituality dimension of the Persisting Effects Questionnaire (PEQ) and Short Index of Mystical Orientation. Regression models identified a range of significant associations between set and setting variables, and intermediate and final mental health and wellbeing outcomes. A generalized structural equation model (GSEM) was then used to verify relationships and associations between endogenous, mediating and final outcome variables concurrently. The present study sheds new light on the influence of ceremonial practices, additional supports and motivations on the therapeutic effects of ayahuasca for mental health and wellbeing, and ways in which such factors can be optimized in naturalistic settings and clinical studies.
阿亚瓦斯卡是一种传统的植物煎剂,含有N,N-二甲基色胺(DMT)和多种β-咔啉,包括哈尔明、哈尔马灵和四氢哈尔明,亚马逊地区的原住民群体一直将其用于仪式性的治疗和精神目的。现在,这种饮品的使用已经远远超出了其最初的消费范围,在新萨满教环境以及基督教融合教会中传播到了北美、欧洲和澳大利亚。虽然这些群体已经建立了自己的仪式和规程来指导使用,但传统或非传统做法的使用在多大程度上可能影响饮用者的急性体验以及长期的幸福感和心理健康结果仍不明确。因此,本研究旨在首次详细评估仪式/仪式特征、额外支持做法、饮用动机与心理健康和幸福感结果之间的关联。本文使用了来自对40多个国家的阿亚瓦斯卡饮用者进行的一项大型横断面研究的数据,这些饮用者在不同背景下使用过阿亚瓦斯卡(n = 6877)。它收集了关于参与者人口统计学、阿亚瓦斯卡饮用模式和历史、消费环境以及所采用的仪式性做法的详细信息。通过凯斯勒10心理困扰量表和SF-12健康问卷的心理健康成分得分来获取当前的心理健康状况,而使用患者总体印象变化工具(PGIC)评估报告的先前临床诊断的焦虑或抑郁(n = 1276)的变化。还评估了各种中间结果,包括感知到的心理健康变化、获得的个人自我洞察数量,以及通过持续影响问卷(PEQ)的灵性维度和神秘取向简短指数测量的主观精神体验。回归模型确定了一系列环境和背景变量与中间和最终心理健康及幸福感结果之间的显著关联。然后使用广义结构方程模型(GSEM)同时验证内生、中介和最终结果变量之间的关系和关联。本研究为仪式性做法、额外支持和动机对阿亚瓦斯卡对心理健康和幸福感的治疗效果的影响,以及在自然环境和临床研究中优化这些因素的方法提供了新的见解。